Open AccessRituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis
Author(s) -
Gema FernándezFresnedo,
Alfonso Segarra,
Ester González,
Simona Alexandru,
R. Delgado,
Natàlia Ramos,
Jesús Egido,
Manuel Praga
Publication year - 2009
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.00570109
Subject(s) - rituximab , medicine , focal segmental glomerulosclerosis , proteinuria , nephrotic syndrome , nephrology , regimen , renal function , renal biopsy , gastroenterology , urology , kidney , lymphoma
Isolated case reports have shown a beneficial effect of rituximab on pediatric patients with primary FSGS, but there is no information about rituximab treatment of FSGS in adults.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom